Japanese wholesalers join up in $2b deal

As was rumored yesterday, Japan's biggest drug wholesaler, Mediceo Paltac, plans a buyout of its closest rival Alfresa in a $2 billion deal that will create a company more than twice as large of its next largest competitor. Report

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.